112 related articles for article (PubMed ID: 2839086)
1. Effect of vasoactive intestinal peptide in man.
Krejs GJ
Ann N Y Acad Sci; 1988; 527():501-7. PubMed ID: 2839086
[No Abstract] [Full Text] [Related]
2. Pancreatic cholera: is the diarrhea due to VIP?
Field M; Chang EB
N Engl J Med; 1983 Dec; 309(24):1513-5. PubMed ID: 6316137
[No Abstract] [Full Text] [Related]
3. Vasoactive intestinal peptide secreting tumors. Pathophysiological and clinical correlations.
Bloom SR; Yiangou Y; Polak JM
Ann N Y Acad Sci; 1988; 527():518-27. PubMed ID: 2839088
[No Abstract] [Full Text] [Related]
4. Somatostatin and analogues in the treatment of VIPoma.
O'Dorisio TM; Gaginella TS; Mekhjian HS; Rao B; O'Dorisio MS
Ann N Y Acad Sci; 1988; 527():528-35. PubMed ID: 2898913
[No Abstract] [Full Text] [Related]
5. Increased tear secretion in pancreatic cholera: a newly recognized symptom in an experiment of nature.
Gilbard JP; Dartt DA; Rood RP; Rossi SR; Gray KL; Donowitz M
Am J Med; 1988 Oct; 85(4):552-4. PubMed ID: 2845780
[No Abstract] [Full Text] [Related]
6. Pancreatic cholera syndrome due to a vasoactive intestinal polypeptide-producing tumor: further insights into the pathophysiology.
Rood RP; DeLellis RA; Dayal Y; Donowitz M
Gastroenterology; 1988 Mar; 94(3):813-8. PubMed ID: 2828145
[TBL] [Abstract][Full Text] [Related]
7. Production of secretory diarrhea by intravenous infusion of vasoactive intestinal polypeptide.
Kane MG; O'Dorisio TM; Krejs GJ
N Engl J Med; 1983 Dec; 309(24):1482-5. PubMed ID: 6316136
[TBL] [Abstract][Full Text] [Related]
8. [The Verner-Morrison syndrome: endocrine cholera or vipoma? (author's transl)].
Charleux H
Nouv Presse Med; 1982 Mar; 11(11):859-62. PubMed ID: 6280131
[TBL] [Abstract][Full Text] [Related]
9. [Vasoactive intestinal peptide-producing tumor (ViPoma)].
Doi R; Tsukada T
Nihon Rinsho; 2006 Sep; Suppl 3():358-62. PubMed ID: 17022564
[No Abstract] [Full Text] [Related]
10. VIP and diarrhoea.
Lancet; 1984 Jan; 1(8370):202. PubMed ID: 6141341
[No Abstract] [Full Text] [Related]
11. Vasoactive intestinal polypeptide.
Fahrenkrug J
Clin Gastroenterol; 1980 Sep; 9(3):633-43. PubMed ID: 6107190
[No Abstract] [Full Text] [Related]
12. Vasoactive intestinal polypeptide-secreting tumours (vipomas) in childhood.
Long RG
J Pediatr Gastroenterol Nutr; 1983; 2(1):122-6. PubMed ID: 6310076
[No Abstract] [Full Text] [Related]
13. [Vasoactive intestinal polypeptide (V.I.P)].
Varsky CG
Acta Gastroenterol Latinoam; 1978 Sep; 8(2):139-70. PubMed ID: 33518
[No Abstract] [Full Text] [Related]
14. Vipoma and watery diarrhea.
Unwin RJ; Calam J; Peart WS; Dimaline R; Lightman SL
N Engl J Med; 1982 Aug; 307(6):377-8. PubMed ID: 6283355
[No Abstract] [Full Text] [Related]
15. [Mechanism of diarrhea and WDHA syndrome].
Ozawa Y; Shishiba Y
Nihon Rinsho; 1982; 40(5):1151-7. PubMed ID: 6288980
[No Abstract] [Full Text] [Related]
16. Modulation of functional gastrointestinal endocrine tumors by endogenous and exogenous somatostatin.
Ellison EC; O'Dorisio TM; Benson GD
Am J Surg; 1986 Jun; 151(6):668-75. PubMed ID: 2872829
[No Abstract] [Full Text] [Related]
17. Vasoactive intestinal peptide (VIP) secreting tumour of the pancreas.
Sandström R; Alhava EM; Poikolainen E; Puittinen J; Soimakallio S
Ann Chir Gynaecol; 1981; 70(3):124-7. PubMed ID: 6275768
[TBL] [Abstract][Full Text] [Related]
18. Secretin, cholecystokinin, and vasoactive intestinal polypeptide in pancreatic cholera.
Achord JL
Ann Intern Med; 1986 Oct; 105(4):632. PubMed ID: 3019205
[No Abstract] [Full Text] [Related]
19. The pancreatic cholera syndrome.
Fuchs SM; Rogers AI
Compr Ther; 1980 Feb; 6(2):66-9. PubMed ID: 6244130
[No Abstract] [Full Text] [Related]
20. Vasoactive intestinal peptide producing tumour contains high density of somatostatin receptors.
Reubi JC; Heitz PU; Gyr K
Lancet; 1987 Mar; 1(8535):741-2. PubMed ID: 2882148
[No Abstract] [Full Text] [Related]
[Next] [New Search]
